Medicinal composition for treating gout
A composition and drug technology, applied in the field of pharmaceutical composition for the treatment of gout, to enhance the therapeutic effect and reduce the effect of inflammatory factors
Active Publication Date: 2017-12-15
CHINA ACAD OF SCI NORTHWEST HIGHLAND BIOLOGY INST
View PDF2 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
At present, Lycium barbarum is widely used as a common edible berry or health food. However, there is no research report on the use of Lycium barbarum or its extracts for the treatment of gout. Reports on Combined Use of Narcisine
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0048] Example 1 Pharmaceutical composition of the present invention
[0049] Take colchicine and Lycium nigra ethanol extract at 0.1:200, add an appropriate amount of filler to prepare granules, tablets, powders and pills.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention provides a medicinal composition for treating gout. The medicinal composition comprises colchicines and black lycium barbarum or an extract of black lycium barbarum. Studies show that a black lycium barbarum ethanol extract is capable of effectively treating gout and reducing inflammation factors, in addition, with the combination of the black lycium barbarum and the colchicines, the treatment effects of the two components on gout can be remarkably improved, and a relatively good option is provided for clinical medication.
Description
technical field [0001] The present invention relates to a pharmaceutical composition for treating gout. Background technique [0002] Gout is a group of heterogeneous diseases caused by long-term purine metabolism disorder and increased blood uric acid causing tissue damage. The clinical features are hyperuricemia (HUA), recurrent gouty acute arthritis, tophi deposition, characteristic chronic arthritis and joint deformities, often involving the kidneys, causing chronic interstitial nephritis and renal uric acid stone formation. The biochemical hallmark of gout is hyperuricemia, which refers to the supersaturation of urate in the extracellular fluid. Urate (monosodium uratecrystal, MSU) is deposited in the form of crystals in the joints and tissues around the joints to cause a series of acute inflammatory reactions, that is, gout. It is generally believed that blood uric acid ≥ 416 μmol / L is hyperuricemia, and about 5%-12% of patients with hyperuricemia will develop gout, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/815A61P19/06A61P29/00A23L33/105A61K31/165
CPCA61K31/165A61K36/815A61K2236/333A23L33/105A61K2300/00
Inventor 索有瑞张弓王洪伦
Owner CHINA ACAD OF SCI NORTHWEST HIGHLAND BIOLOGY INST


